A New Jersey pharmaceutical company is recalling some lots of its lidocaine hydrochloride topical solution because it may be “super potent.” According to an announcement with the U.S. Food and Drug ...
Anesthesia is an important part of modern medicine. It’s hard to grasp how in the past people underwent surgeries without numbing their sensations first. Luckily, in the 21 st century, we have a ...
Scilex Holding Company announced completion of its SP-103 Phase 2 study to evaluate the safety and efficacy in subjects with acute LBP. The Phase 2, randomized, double-blind, placebo-controlled, ...
The Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ZTlido ® (lidocaine topical system; Scilex Pharmaceuticals) to include additional ...
One hundred and five patients scheduled for cataract surgery with topical anaesthesia were randomly allocated into 3 groups of 35 patients each to receive eye drops of lidocaine 2%, levobupivacaine ...
May 13, 2005 (San Francisco) — A 5% topical lidocaine gel that is administered intravaginally has promise for treating chronic dysmenorrhea, according to investigators whose findings were presented ...
Scilex Holding Company, an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, ...
CHICAGO — The application of topical liquid lidocaine to the vulvar vestibule allows for comfortable intercourse in breast cancer survivors with severe menopausal dyspareunia, new research shows.
A New Jersey pharmaceutical company is recalling some lots of its lidocaine hydrochloride topical solution because it may be “super potent.” According to an announcement with the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback